CD274 and non-small cell lung carcinoma: (2024) designed a prospective study using the STRESS-LUNG-1 NSCLC cohort treated with various kinds of anti-PD-1/PD-L1 inhibitors, and found that patients with baseline ED (high ED and moderate ED) had significantly shorter DFS, OS, and smaller ORR compared with no ED patients (108).